Global Citizenship: What I’ve Learned About the American PCB Business
Global Sourcing Spotlight: The Best Products to Buy Offshore Through Global Sourcing
Nolan's Notes: The Rise (and Risk) of Data
Inovar Remains Open as an Essential Company Critical to Public Safety
April 1, 2020 | Inovar, Inc.Estimated reading time: 2 minutes
Inovar, Inc., a full-service Electronics Manufacturing Services (EMS) provider, announces that it has been designated as a “Critical/Essential Supplier” and will stay open during the COVID-19 pandemic.
Inovar’s medical customers, including BioFire, have designated Inovar as critical to their operations and public safety. BioFire’s diagnostic equipment has just been authorized by FDA under an emergency use authorization (EUA) for use by authorized laboratories to diagnose COVID-19 in 45 minutes.
“As a supplier to businesses that are working to support our country against COVID-19, such as BioFire, the raw materials that you are providing are essential to the manufacturing of very important rapid tests that will aid in the detection of COVID-19, and another test currently used in the detection of a broad range of respiratory illnesses. These tests are essential in the fight against this pandemic,” stated Utah Governor Gary R. Herbert in a letter to Inovar.
With more than 25 years of molecular experience, BioFire Diagnostics, LLC sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux’s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and CE-IVD marked assays for more pathogens. BioFire Diagnostics has produced the easiest, fastest, and most comprehensive multiplex PCR testing available: the BioFire System.
In collaboration with the Department of Defense, BioFire Defense has developed a fully-automated, sample-to-result assay for the specific detection of SARS-CoV-2, the causative agent of COVID-19. This assay is designed to run on both the BioFire® FilmArray® 2.0 and BioFire® FilmArray® Torch Systems, delivering results in about 45 minutes. After meeting initial DoD demand, commercial availability under EUA is anticipated in April 2020.
In parallel, BioFire Diagnostics is developing new SARS-CoV-2-specific assays for addition to the BioFire® FilmArray® Respiratory 2 (RP2) Panel. This new panel will be named the BioFire® Respiratory 2.1 (RP2.1) Panel and is being developed for both the BioFire 2.0 and BioFire Torch Systems. In addition to the detection of SARS-CoV-2, the BioFire RP2.1 Panel will detect 21 additional respiratory pathogens to help clinicians quickly rule in and rule out other common causes of respiratory illness in about 45 minutes. Development of the BioFire RP2.1 Panel is also occurring on an accelerated timeline, and submission to the FDA for EUA and 510(k) clearance is anticipated in Q3 of 2020.
Inovar’s Logan and Tecate factories are in full production mode and will stay that way due to the critical medical nature of products the company provides to BioFire and its other medical customers.
To that end, Inovar is working diligently to keep its workplace productive and healthy during the pandemic. Social distancing, fewer interactions and good hygiene help the factories and its employees maintain the quality support that its customers rely upon.
“As the world works to overcome COVID-10, Inovar is doing its part by staying in close contact with BioFire and our other medical customers as we prioritize supplying the materials needed to meet their vital demand,” said Craig Rupp, Inovar Inc. CEO.
Share on:
Suggested Items
BOOK EXCERPT: The Printed Circuit Designer’s Guide to... DFM Essentials, Chapter 2
11/14/2024 | I-Connect007 Editorial TeamThe guidelines offered in this book are based on both ASC recommendations and IPC standards with the understanding that some may require adjustment based on the material set, fabricator processes, and other design constraints. This chapter discusses panelization, placing PCBs on manufacturing panels, highlighting features like coupons, borders, and scoring to maximize material utilization and reduce costs, and detailing preferred panel sizes and modifications.
Smartphone Panel Shipments to Dip by 1.7% in 2025, with Chinese Manufacturers’ Share Expected to Exceed 70%
11/13/2024 | TrendForceTrendForce’s latest investigations reveal that while the overall smartphone market is projected to grow by just 3% in 2024, increased demand for refurbishes and second-hand devices is fueling growth in the smartphone panel market. Shipments this year are estimated to grow 6.7% YoY to reach 2.066 billion units.
Automating Test Processes in Modern PCBA Manufacturing
11/12/2024 | Josh Casper, Horizon SalesICT and functional test play critical roles in the electronics manufacturing process. In many cases, these processes are the final line of defense in identifying defects, preventing failures from reaching the end user, and safeguarding a manufacturer's reputation. A growing problem in this area has been the sheer increase in production output from the SMT line. As components get smaller, PCBs will continue shrinking, allowing engineers to design highly panelized products.
TTM’s Grand Opening in Malaysia
11/07/2024 | Marcy LaRont, I-Connect007When I last spoke with Tom Edman, president and CEO of TTM Technologies (TTM), he provided an update about the company’s new high-tech printed circuit board facility under construction in Syracuse, New York, and how the grand opening of a facility in Malaysia is informing TTM’s overall expansion efforts: a cutting-edge facility spread across 27 acres and providing roughly 1,000 jobs. Now, Tom provides more details about the new automated facility, its regional and global impact, and the importance of having both government and industry support.
Altus Sees Growing Interest for Laser Depanelling Solutions
11/04/2024 | Altus GroupAltus Group, a leading distributor of capital equipment in the UK and Ireland, has seen an increasing interest in laser depaneling systems from LPKF in 2024.